BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36151551)

  • 1. An analysis of time trends in breast and prostate cancer mortality rates in Lithuania, 1986-2020.
    Everatt R; Gudavičienė D
    BMC Public Health; 2022 Sep; 22(1):1812. PubMed ID: 36151551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and age-period-cohort analysis of upper aerodigestive tract and stomach cancer mortality in Lithuania, 1987-2016.
    Kuzmickiene I; Everatt R
    Public Health; 2021 Jul; 196():62-68. PubMed ID: 34153634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in cervical cancer mortality rates in Lithuania, 1987-2016.
    Everatt R; Intaitė B
    Cancer Epidemiol; 2018 Dec; 57():85-89. PubMed ID: 30347336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in Breast Cancer Incidence and Stage Distribution Before and During the Introduction of the Mammography Screening Program in Lithuania.
    Steponaviciene L; Briediene R; Vanseviciute R; Smailyte G
    Cancer Control; 2019; 26(1):1073274818821096. PubMed ID: 30808202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Mortality Rates of Corpus Uteri and Ovarian Cancer in Lithuania, 1987-2016.
    Everatt R; Intaitė B
    Medicina (Kaunas); 2020 Jul; 56(7):. PubMed ID: 32668695
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate cancer in Denmark 1978-2009--trends in incidence and mortality.
    Outzen M; Brasso K; Martinussen N; Christensen J; Tjønneland A; Friis S; Olsen A
    Acta Oncol; 2013 May; 52(4):831-6. PubMed ID: 22809166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of prostate cancer in Lithuania after introduction of the Early Prostate Cancer Detection Programme.
    Smailyte G; Aleknaviciene B
    Public Health; 2012 Dec; 126(12):1075-7. PubMed ID: 22381571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer incidence and mortality before and after implementation of the German mammography screening program.
    Katalinic A; Eisemann N; Kraywinkel K; Noftz MR; Hübner J
    Int J Cancer; 2020 Aug; 147(3):709-718. PubMed ID: 31675126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer mortality in Mexico: an age-period-cohort analysis.
    Franco-Marina F; Lazcano-Ponce E; López-Carrillo L
    Salud Publica Mex; 2009; 51 Suppl 2():s157-64. PubMed ID: 19967270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China.
    Liu X; Yu C; Bi Y; Zhang ZJ
    Public Health; 2019 Jul; 172():70-80. PubMed ID: 31220754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in female breast cancer incidence, mortality, and survival in Austria, with focus on age, stage, and birth cohorts (1983-2017).
    Ilic L; Haidinger G; Simon J; Hackl M; Schernhammer E; Papantoniou K
    Sci Rep; 2022 Apr; 12(1):7048. PubMed ID: 35487918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer Screening Program in Lithuania: Trends in Breast Cancer Mortality Before and During the Introduction of the Mammography Screening Program.
    Steponavičienė L; Briedienė R; Vansevičiūtė-Petkevičienė R; Gudavičienė-Petkevičienė D; Vincerževskienė I
    Acta Med Litu; 2020; 27(2):61-69. PubMed ID: 34113210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing Incidence and Stage Distribution of Prostate Cancer in a Lithuanian Population-Evidence from National PSA-Based Screening Program.
    Patasius A; Smailyte G
    Int J Environ Res Public Health; 2019 Dec; 16(23):. PubMed ID: 31816821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time trends in lung-cancer mortality rates among men in Lithuania, 1965-1994.
    Petrauskaite R; Gurevicius R
    Int J Cancer; 1996 May; 66(3):294-6. PubMed ID: 8621245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer mortality trends in the Umbria region of Italy 1978-2004: a joinpoint regression analysis.
    Stracci F; Canosa A; Minelli L; Petrinelli AM; Cassetti T; Romagnoli C; La Rosa F
    BMC Cancer; 2007 Jan; 7():10. PubMed ID: 17227578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunistic testing versus organized prostate-specific antigen screening: outcome after 18 years in the Göteborg randomized population-based prostate cancer screening trial.
    Arnsrud Godtman R; Holmberg E; Lilja H; Stranne J; Hugosson J
    Eur Urol; 2015 Sep; 68(3):354-60. PubMed ID: 25556937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer incidence and mortality in the Baltic states, Belarus, the Russian Federation and Ukraine.
    Patasius A; Innos K; Barchuk A; Ryzhov A; Leja M; Misins J; Yaumenenka A; Smailyte G
    BMJ Open; 2019 Oct; 9(10):e031856. PubMed ID: 31601600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: population-based study.
    Mukhtar TK; Yeates DR; Goldacre MJ
    J R Soc Med; 2013 Jun; 106(6):234-42. PubMed ID: 23761583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast and prostate cancer: an analysis of common epidemiological features in mortality trends in Spain.
    López-Abente G; Mispireta S; Pollán M
    BMC Cancer; 2014 Nov; 14():874. PubMed ID: 25421124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing predicted age-specific breast cancer mortality rates in 27 European countries by 2020.
    Clèries R; Rooney RM; Vilardell M; Espinàs JA; Dyba T; Borras JM
    Clin Transl Oncol; 2018 Mar; 20(3):313-321. PubMed ID: 28726040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.